CYTK Historical Earnings image   This CYTK historical earnings page last updated 8/8/2022
CYTK Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.09B
Q1 20225/4/20220.00B
Q4 20212/24/20220.06B
Q3 202111/3/20210.01B
Q2 20218/5/20210.00B
Q1 20215/6/20210.01B
Q4 20202/25/20210.01B
Q3 202011/4/20200.04B
Q2 20208/6/20200.00B
Q1 20205/6/20200.00B
Q4 20193/3/20200.01B
Q3 201910/31/20190.01B
Q2 20198/8/20190.01B
Q1 20195/9/20190.01B
Q4 20182/21/20199.38M
Q3 201811/1/201810.64M
Q2 20187/26/20186.21M
Q1 20184/26/20185.27M
Q4 20172/15/2018-18000
Q3 201710/26/20176.18M
Q2 20178/2/20173.05M
Q1 20174/27/20174.15M
Q4 20162/16/201733.14M
Q3 201610/27/201659.05M
Q2 20167/28/20165.80M
Q1 20164/28/20168.42M
Q4 20152/16/20169.76M
Q3 201510/29/20157.95M
Q2 20157/29/20156.54M
Q1 20154/30/20154.41M
Q4 20142/12/201521.76M
Q3 201410/30/20149.40M
Q2 20147/30/20147.80M
Q1 20145/6/20148.00M
Q4 20132/6/201424.30M
Q3 201310/30/201312.60M
Q2 20137/31/20131.00M
Q1 20134/30/2013821000
Q4 20122/5/20132.20M
Q3 201210/30/20121.70M
Q2 20127/31/20121.80M
Q1 20124/26/20121.80M
CYTK Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/4/2022-0.230
Q1 20225/4/2022-1.020
Q4 20212/24/2022-0.360
Q3 202111/3/2021-0.950
Q2 20218/5/2021-0.860
Q1 20215/6/2021-0.660
Q4 20202/25/2021-0.620
Q3 202011/4/2020-0.050
Q2 20208/6/2020-0.680
Q1 20205/6/2020-0.660
Q4 20193/3/2020-0.520
Q3 201910/31/2019-0.500
Q2 20198/8/2019-0.560
Q1 20195/9/2019-0.540
Q4 20182/21/2019-0.48
Q3 201811/1/2018-0.4
Q2 20187/26/2018-0.51
Q1 20184/26/2018-0.56
Q4 20172/15/2018-0.75
Q3 201710/26/2017-0.6
Q2 20178/2/2017-0.6
Q1 20174/27/2017-0.62
Q4 20162/16/20170.16
Q3 201610/27/20160.74
Q2 20167/28/2016-0.29
Q1 20164/28/2016-0.31
Q4 20152/16/2016-0.24
Q3 201510/29/2015-0.23
Q2 20157/29/2015-0.27
Q1 20154/30/2015-0.23
Q4 20142/12/20150.23
Q3 201410/30/2014-0.16
Q2 20147/30/2014-0.23
Q1 20145/6/2014-0.27
Q4 20132/6/20140.21
Q3 201310/30/2013-0.43
Q2 20137/31/2013-0.58
Q1 20134/30/2013-0.540
Q4 20122/5/2013-0.420
Q3 201210/30/2012-0.420
Q2 20127/31/2012-0.780
Q1 20124/26/2012-0.780
Quotes delayed 20 minutes

Email EnvelopeFree CYTK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cytokinetics (CYTK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DARE Historical Earnings
DAWN Historical Earnings
DBTX Historical Earnings
DCPH Historical Earnings
DCTH Historical Earnings
DERM Historical Earnings
DFFN Historical Earnings
DGX Historical Earnings
DHR Historical Earnings
DICE Historical Earnings
What was the record high CYTK historical earnings result?
In terms of earnings or revenue, what is the best CYTK historical earnings result that Cytokinetics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CYTK historical earnings result was set in Q3 2016, when Cytokinetics posted results of 0.74/share. The most successful revenue quarter within our data set was Q2 2022 when Cytokinetics reported revenue of 0.09B.

What was the lowest Cytokinetics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CYTK has reported, and when?

✔️Accepted answer: Within our data set, the lowest CYTK historical earnings result was set in Q1 2022, when Cytokinetics posted results of -1.020/share. The smallest revenue quarter within our data set was Q4 2017 when Cytokinetics reported revenue of -18000.

On this page we presented the CYTK historical earnings date information for Cytokinetics. Reviewing that CYTK Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2016, when CYTK posted gaap of 0.74/share. Meanwhile the lowest CYTK historical earnings result was in Q1 2022, when CYTK posted gaap of -1.020/share. Moving to Cytokineticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when CYTK reported 0.09B in revenue, while the smallest revenue quarter was Q4 2017 when CYTK reported -18000 in revenue.

For self directed investors doing their due diligence on CYTK or any other given stock, their research can benefit from looking into all of the Cytokinetics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Cytokinetics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CYTK. Thanks for visiting, and the next time you need to research CYTK historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SPGP Dividend History, FRXX Insider Buying, ROOT Insider Buying.

 

CYTK Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.